Warren Buffett Merck & Co., Inc. Transaction History

Berkshire Hathaway Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $656 Million - $722 Million	-9,157,192 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $613 Million - $679 Million	-8,725,196 Reduced 48.79%	9,157,192 $712 Million
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $745 Million - $877 Million	-10,815,047 Reduced 37.69%	17,882,388 $1.38 Billion
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $452 Million - $501 Million	6,294,333 Added 28.1%	28,697,435 $2.35 Billion
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $1.64 Billion - $1.86 Billion	22,403,102 New	22,403,102 $1.86 Billion

3,819

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Berkshire Hathaway Inc, based on Form 13F filings with the SEC.

Stay updated on Berkshire Hathaway Inc and Warren Buffett with notifications on news.